SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950137-03-005842
Filing Date
2003-11-12
Accepted
2003-11-12 09:21:59
Documents
7
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT c80743e10vq.htm 10-Q 187367
3 STATEMENT RE: COMPUTATION OF EARNINGS PER SHARE c80743exv11.htm EX-11 19651
4 STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS c80743exv12.htm EX-12 17606
5 CERTIFICATION OF CEO c80743exv31w1.htm EX-31.1 6358
6 CERTIFICATION OF CFO c80743exv31w2.htm EX-31.2 6535
7 SECTION 1350 CERTIFICATION c80743exv32.htm EX-32 3656
8 CAUTIONARY STATEMENT c80743exv99.htm EX-99 8031
  Complete submission text file 0000950137-03-005842.txt   251531
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 03990884
SIC: 2834 Pharmaceutical Preparations